GDP certification successfully renewed at GLS Germany
- Quality, safety and hygiene of medication deliveries confirmed
- Certification for non-temperature-controlled and passively temperature-controlled consignments
Neuenstein, 4 November 2019. GLS Germany remains certified in accordance with the Good Distribution Practice (GDP) guidelines for the transport of medicinal products. The parcel company received confirmation in August. GLS Germany has been compliant with the stringent requirements for pharmaceutical deliveries since 2016.
GLS Germany adapted its internal processes in line with the European guidelines on the transport of medicinal products for human use several years ago – and has been optimising them continuously ever since. Compliance with GDP guidelines is audited annually by renowned certification body DQS. This year’s result: GLS continues to satisfy all requirements – with no exceptions.
“Stringent hygiene requirements apply in respect of pharmaceutical deliveries. This successful renewal of our certification pays testament to our high standards of transport quality and safety,” says Martin Seidenberg, Chairman of the GLS Germany Management Board. “As such, GLS customers still have the option of sending both medications and medical devices in a safe and appropriate fashion.”
Industry-specific service options
GLS Germany has been offering the PharmaService since 2016, enabling GDP-compliant shipping. Customers can book the service for the shipping of non-temperature-sensitive pharmaceutical products.
GLS also offers its customers GDP-compliant delivery of temperature-sensitive, passively temperature-controlled goods: on request, GLS will deliver products provided in validated thermal packaging within 24 hours.